Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Gefitinib is superior to carboplatin-paclitaxel as an initial treatment for pulmonary adenocarcinoma among nonsmokers or former light smokers in East Asia. The presence in the t...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 8,112
- Institution
- AstraZeneca (Japan)
External Links
Identifiers
- ORCID
- 0009-0002-8677-6821
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.